Welgene Biotech Co.,Ltd. 6661.TWO Stock
Welgene Biotech Co.,Ltd. Price Chart
Welgene Biotech Co.,Ltd. 6661.TWO Financial and Trading Overview
| Welgene Biotech Co.,Ltd. stock price | 22.4 TWD |
| Previous Close | 23.6 TWD |
| Open | 24.25 TWD |
| Bid | 23.75 TWD x 0 |
| Ask | 23.85 TWD x 0 |
| Day's Range | 23.8 - 24.25 TWD |
| 52 Week Range | 20.1 - 27.25 TWD |
| Volume | 17.07K TWD |
| Avg. Volume | 18.43K TWD |
| Market Cap | 554.64M TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 58.04878 |
| EPS (TTM) | -0.11 TWD |
| Forward Dividend & Yield | 0.18 (0.76%) |
| Ex-Dividend Date | March 16, 2023 |
| 1y Target Est | N/A |
6661.TWO Valuation Measures
| Enterprise Value | 549.97M TWD |
| Trailing P/E | 58.04878 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.8258535 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Welgene Biotech Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 7.02% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.25 TWD |
| 52 Week Low | 20.1 TWD |
| 50-Day Moving Average | 22.93 TWD |
| 200-Day Moving Average | 22.7 TWD |
6661.TWO Share Statistics
| Avg. Volume (3 month) | 18.43K TWD |
| Avg. Daily Volume (10-Days) | 70.4K TWD |
| Shares Outstanding | 23.3M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 65.77% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.432 |
| Last Split Factor | 1080:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 13.81 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 141.8M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 13.035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Welgene Biotech Co.,Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 3, Yuanyuan Street |
| ZIP | 11503 |
| Phone | 886 2 6616 0001 |
| Website | https://www.welgene.com.tw |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Welgene Biotech Co.,Ltd. provides genetic testing services. The company offers research services, including sequencing, microarray, qPCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and Cytoscan, an array-based comparative genomic hybridization. It also provides reagents, consumable supplies, and instruments, as well as software services. The company was founded in 2003 and is based in Taipei City, Taiwan.
Q&A For Welgene Biotech Co.,Ltd. Stock
What is a current 6661.TWO stock price?
Welgene Biotech Co.,Ltd. 6661.TWO stock price today per share is 22.4 TWD.
How to purchase Welgene Biotech Co.,Ltd. stock?
You can buy 6661.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Welgene Biotech Co.,Ltd.?
The stock symbol or ticker of Welgene Biotech Co.,Ltd. is 6661.TWO.
Which industry does the Welgene Biotech Co.,Ltd. company belong to?
The Welgene Biotech Co.,Ltd. industry is Diagnostics & Research.
How many shares does Welgene Biotech Co.,Ltd. have in circulation?
The max supply of Welgene Biotech Co.,Ltd. shares is 23.3M.
What is Welgene Biotech Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Welgene Biotech Co.,Ltd. PE Ratio is now.
What was Welgene Biotech Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Welgene Biotech Co.,Ltd. EPS is -0.11 TWD over the trailing 12 months.
Which sector does the Welgene Biotech Co.,Ltd. company belong to?
The Welgene Biotech Co.,Ltd. sector is Healthcare.